P3 Health Partners Inc. (PIII) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
PIII EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PIII Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -21.4% | -9.1% |
| 2023 | 100.0% | -13.3% | -4.6% |
| 2022 | 100.0% | -148.7% | -25.7% |
| 2021 | -4.8% | -29.5% | -24.6% |
| 2020 | 100.0% | -5.8% | -6.4% |
Download Data
Export PIII earnings history in CSV or JSON format
Free sign-in required to download data
P3 Health Partners Inc. (PIII) Earnings Overview
As of May 8, 2026, P3 Health Partners Inc. (PIII) reported trailing twelve-month net income of -$131M, reflecting -77.6% year-over-year growth. The company earned $-40.10 per diluted share over the past four quarters, with a net profit margin of -9.1%.
Looking at the long-term picture, PIII's historical earnings data spans multiple years. The company achieved its highest annual net income of -$31M in fiscal 2020.
P3 Health Partners Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AGIO (-$423M net income, -764.0% margin), ALHC ($20M net income, -0.0% margin), OSCR (-$39M net income, -3.8% margin), PIII has outperformed on profitability metrics. Compare PIII vs AGIO →
PIII Earnings vs Peers
Earnings metrics vs comparable public companies
PIII Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$136M | -135.1% | -$321M | $-54.06 | -9.1% | -21.4% |
| 2023 | -$58M | +78.6% | -$168M | $-30.44 | -4.6% | -13.3% |
| 2022 | -$270M | -72.6% | -$1.56B | $-324.84 | -25.7% | -148.7% |
| 2021 | -$156M | -398.2% | -$188M | $-188.17 | -24.6% | -29.5% |
| 2020 | -$31M | +25.2% | -$29M | $-39.73 | -6.4% | -5.8% |
| 2019 | -$42M | - | -$40M | $-44.10 | -28.8% | -27.2% |
See PIII's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PIII Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PIII vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPIII — Frequently Asked Questions
Quick answers to the most common questions about buying PIII stock.
Is PIII growing earnings?
PIII EPS fell to $-40.10, with earnings declining -77.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-131M.
What are PIII's profit margins?
P3 Health Partners Inc. net margin is -9.1%, with operating margin at -21.4%. Below-average margins reflect competitive or cost pressures.
How consistent are PIII's earnings?
PIII earnings data spans 2019-2024. The declining earnings trend is -77.6% YoY. Historical data enables comparison across business cycles.